Rocket Lab (RKLB) stock analysis: Q1 revenue up 63%, $2.2B backlog, $8B Iridium deal pending, and $190M defense contract. Key risks and price targets. The postRocket Lab (RKLB) stock analysis: Q1 revenue up 63%, $2.2B backlog, $8B Iridium deal pending, and $190M defense contract. Key risks and price targets. The post

Rocket Lab (RKLB) Stock: Why This Space Stock Is Outperforming Expectations

2026/07/09 22:45
4 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Key Takeaways

  • Rocket Lab delivered Q1 revenue of $200.3 million, marking a 63.5% increase compared to the same period last year, with a contract backlog reaching $2.2 billion
  • An $8 billion acquisition of Iridium Communications is pending, which would integrate an operational satellite constellation serving 2.5 million subscribers
  • The company secured a $190 million HASTE agreement with Kratos Defense, representing its largest launch contract to date
  • Wall Street consensus rates the stock a “Moderate Buy” with a mean price target of $108.24, compared to the current trading price near $83.91
  • Notable headwinds include Neutron development setbacks, continued quarterly losses, significant insider share disposals, and reliance on key customers

Rocket Lab (RKLB) is currently priced at $83.91, having retreated from its 52-week peak of $151.00, amid a broader sector cooldown following the excitement around SpaceX’s public market debut.


RKLB Stock Card
Rocket Lab USA, Inc., RKLB

The addition of SpaceX to the Nasdaq-100 index on July 7 captured significant investor interest and redirected funds into aerospace equities. Yet Rocket Lab’s trajectory offers compelling fundamentals that stand on their own merit.

First-quarter revenue reached $200.3 million, representing a 63.5% year-over-year surge and surpassing Wall Street’s consensus estimate of $189.65 million. GAAP gross margin improved to 38.2%, while the contract backlog expanded 20.2% from the previous quarter to $2.2 billion.

During the first quarter, the firm executed 31 new agreements for its Electron launch vehicle and HASTE services, alongside five additional reservations for Neutron, the company’s next-generation rocket currently under development. By quarter-end, more than 70 committed launches populated the company’s order book.

Management projected Q2 revenue between $225 million and $240 million, implying approximately 16% sequential expansion at the midpoint.

Iridium Acquisition Transforms Business Model

The proposed $8 billion takeover of Iridium Communications (IRDM) represents a strategic pivot. Iridium currently maintains an active low-Earth-orbit satellite constellation serving over 2.5 million subscribers spanning government agencies, aviation, maritime industries, and defense organizations.

Should the transaction finalize, Rocket Lab will transition from purely manufacturing and launching satellites to also managing orbital infrastructure and delivering telecommunications services directly. This shift fundamentally alters the revenue profile and expands the total addressable market significantly.

In March 2026, the company finalized a $190 million HASTE agreement with Kratos Defense supporting the U.S. Department of Defense’s MACH-TB 2.0 hypersonic test initiative. The contract encompasses 20 test missions across four years and stands as the most valuable single deal in corporate history. Defense-related revenue streams are increasingly material to overall performance.

Institutional capital continues flowing in. Swedbank AB expanded its position by 11.4% during Q1, purchasing 58,081 additional shares to bring its total holdings to 567,331 shares, worth approximately $36.4 million. Institutional ownership now comprises 71.78% of outstanding shares.

Significant Challenges Remain

Neutron, the heavy-lift vehicle essential for larger government and commercial payloads, has been rescheduled to Q4 2026 following technical complications. Additional postponements would likely pressure investor sentiment and the share price.

Profitability remains elusive. The company posted a net loss of $45 million in Q1, with adjusted EBITDA losses forecast between $20 million and $26 million for the current quarter.

Revenue concentration presents another vulnerability. The five largest customers generated 49% of 2025 revenue, while the top five backlog accounts represent 77% of committed future business. U.S. government contracts alone comprised 47% of 2025 revenue.

Insider transactions have accelerated recently. CFO Adam Spice divested $8.9 million in shares during May, while SVP Arjun Kampani sold $9.5 million worth in June. Collectively, insiders have liquidated $362.8 million in stock over the trailing 90-day period.

Analyst price objectives span from $96 to $150, with Morgan Stanley’s optimistic scenario reaching $293. The consensus rating stands at “Moderate Buy” with a mean target of $108.24—representing meaningful upside from current levels.

Rocket Lab successfully executed the U.S. Space Force’s VICTUS HAZE mission ahead of the projected timeline, achieving a record turnaround for responsive launch operations that management believes strengthens the company’s standing in national security space missions.

The post Rocket Lab (RKLB) Stock: Why This Space Stock Is Outperforming Expectations appeared first on Blockonomi.

Market Opportunity
LAB Logo
LAB Price(LAB)
$1.03355
$1.03355$1.03355
+3.92%
USD
LAB (LAB) Live Price Chart

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

$5M in SPCX Positions for Free

$5M in SPCX Positions for Free$5M in SPCX Positions for Free

0 fees, 100x leverage, daily prizes, 7K+ stocks/ETFs